ورود به حساب

نام کاربری گذرواژه

گذرواژه را فراموش کردید؟ کلیک کنید

حساب کاربری ندارید؟ ساخت حساب

ساخت حساب کاربری

نام نام کاربری ایمیل شماره موبایل گذرواژه

برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید


09117307688
09117179751

در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید

دسترسی نامحدود

برای کاربرانی که ثبت نام کرده اند

ضمانت بازگشت وجه

درصورت عدم همخوانی توضیحات با کتاب

پشتیبانی

از ساعت 7 صبح تا 10 شب

دانلود کتاب Amyloidosis

دانلود کتاب آمیلوئیدوز

Amyloidosis

مشخصات کتاب

Amyloidosis

ویرایش: 1 
نویسندگان: , , , , , , ,   
سری:  
ISBN (شابک) : 9781461292920, 9781461321996 
ناشر: Springer US 
سال نشر: 1986 
تعداد صفحات: 810 
زبان: English 
فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود) 
حجم فایل: 25 مگابایت 

قیمت کتاب (تومان) : 36,000



کلمات کلیدی مربوط به کتاب آمیلوئیدوز: روانپزشکی



ثبت امتیاز به این کتاب

میانگین امتیاز به این کتاب :
       تعداد امتیاز دهندگان : 9


در صورت تبدیل فایل کتاب Amyloidosis به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.

توجه داشته باشید کتاب آمیلوئیدوز نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.


توضیحاتی در مورد کتاب آمیلوئیدوز



از فرآیندی که از زمان ویر چاو و روکیتانسکی، عمدتاً علاقه نسبتاً محدود پاتولوژیست‌ها را برانگیخت، آمیلوئیدوز به‌عنوان یکی از مهم‌ترین مجموعه‌های بیماری به‌طور کامل مطرح شد. وجود آن غالب است: ضایعات بیماری آلزایمر، بیماری که حدود 2.5 میلیون نفر را در ایالات متحده تحت تاثیر قرار می دهد و در نتیجه سکته مغزی به عنوان سومین علت شایع مرگ و میر رقیب نزدیک است. اگر همانطور که توضیح داده شد، بیماری آلزایمر "بیماری قرن" است، امی لویدوزیس مجموعه بیماری اعصار است. این بیماری در یک یا چند مورد از تظاهرات خود بر هر عضو بدن تأثیر می گذارد و حداقل به اندازه مومیایی های مصری مبتلا به اهرام است. با افزایش درصد افراد مسن تر، آمیلوئید در جمعیت سالمندان به طور فزاینده ای بیشتر می شود. موضوعات تحت پوشش در این سمپوزیوم تقریباً در هر تخصص پزشکی بالینی است. از میانگین یک مقاله در هر یک از سه سمپوزیوم گذشته، علاقه انفجاری به آمیلوئیدوز مغزی منجر به ارائه 12 مقاله در این زمینه در جلد حاضر شده است. فرآیندهای آمیلوئیدوتیک خانوادگی مستعد ژنتیکی، مانند پلی نوروپاتی ها و تب مدیترانه ای فامیلی نیز تحقیقات گسترده و جالبی را تحریک کرده اند که اثر چشمگیر یک جایگزینی اسید آمینه منفرد را در تبدیل یک پروتئین طبیعی به پروتئین نشان داده است. یک \"آمیلوئیدوژن\" کشنده.


توضیحاتی درمورد کتاب به خارجی

From a process that from the days of Vir chow and Rokitansky, primarily stimulated the relatively narrow interest of pathologists, amyloidosis has risen full-blown as one of the most important of disease complexes. Its presence dominat:es the lesions of Alzheimer's disease, a disease affecting an estimated 2. 5 million people in the U. S. A. and thereby closely rivaling stroke as the third most common cause of death. If, as it has been de­ scribed, Alzheimer's disease is the "Disease of the Century," then amy­ loidosis is the Disease Complex of the Ages. It affects in one or more of its manifestations every organ of the body, and is at least as old as the afflicted Egyptian mummies of the pyramids. With an increasing percentage of older individuals amyloid of the senior population becomes increasingly more frequent. The subjects covered in this Symposium range through almost every clinical medical specialty. From an average of one paper in each of the past three Symposiums, the explosive interest in cerebral amyloidosis has led to the presentation of 12 papers on this subject in the present volume. The genetically predisposed familial amyloidotic processes, such as the polyneuropathies and familial Mediterranean fever have also stimulated ex­ tensive and intriguing investigations which have revealed the striking effect of a single amino acid substitution in transforming a normal protein into. a lethal "amyloidogenic" one.



فهرست مطالب

Front Matter....Pages i-xvii
Front Matter....Pages 1-1
Protein AA and Associated Proteins in Type-AA Amyloid Substance....Pages 3-10
Heterogeneity of Human Amyloid Protein AA and SAA....Pages 11-18
Vascular AA Amyloidosis is Characterized by Special Protein AA Subspecies....Pages 19-26
The Physico-Chemical, Antigenic, and Functional Heterogeneity of Human Serum Amyloid A....Pages 27-38
Reaggregation of Bovine Amyloid a Fibril Components to β-Pleated Sheet Fibrillar Structures....Pages 39-48
Analysis of X-Ray Scattering by Human AA Fibrils Using Secondary Structure Predictions of Human SAA 1 ....Pages 49-55
Characterization of Two Distinct Serum Amyloid A Gene Products Defined by Their Complementary DNAs....Pages 57-60
Human Serum Amyloid Genes — Molecular Characterization....Pages 61-68
Kinetics of Human Serum Amyloid A....Pages 69-77
Ultrastructural Identification of AA-Type Amyloid Fibrils Using Polyclonal and Monoclonal Antibodies....Pages 79-85
Human Serum Amyloid P-Component (SAP) as an Acute Phase Reactant in the Female....Pages 87-97
Front Matter....Pages 99-99
Pathogenetic Mechanisms and Precursor Product Relationships in Murine Amyloidosis....Pages 101-108
A Possible Effect of Oral Tolerance in Casein Induced Murine Amyloidosis?....Pages 109-113
Isolation and Characterization of Amyloid Enhancing Factor (AEF)....Pages 115-121
Enhancement of Amyloid Degradation by Ascorbic Acid: In Vivo Evidence in a Murine Model....Pages 123-127
Effect of Colchicine on the Acute Phase Serum Amyloid a Protein Response and Splenic Amyloid Deposition During Experimental Murine Inflammation....Pages 129-137
Serum Amyloid A Protein (SAA) from Mink, Horse, and Man: A Comparative Study....Pages 139-147
The Time Relationship Between Amyloid Deposition and Glycosaminoglycan Accumulation During Experimental Amyloidosis....Pages 149-156
Kinetics of Selective Deposition of ApoSAA 2 During Development of Amyloidosis in Mice....Pages 157-161
In Vivo Radioimmunodetection of Amyloid Deposits in Experimental Amyloidosis....Pages 163-174
Front Matter....Pages 99-99
Prostacyclin and Thromboxane Production from Macrophages of Amyloid Resistant and Sensitive Mice....Pages 175-185
Front Matter....Pages 187-187
Regulation of Serum Amyloid a Synthesis in Primary Mouse Hepatocyte Cultures....Pages 189-192
Immunoelectron Microscopic Study of Liver in Experimental Murine Amyloidosis Using Anti-Mouse AA Antiserum....Pages 193-199
Immunocytochemical Studies on the Site of Synthesis and Pathways of Amyloid Protein AA....Pages 201-208
A Comparison of Serum Amyloid A (SAA) Synthesis with that of the Pentraxins: Serum Amyloid P (SAP) and C-Reactive Protein (CRP)....Pages 209-215
Further Studies on the Mechanism of Action of Surface Associated Proteolytic Enzymes on Lymphocytes and Monocytes which Degrade SAA Precursor to AA-Like Products....Pages 217-223
Down-Regulation of Kupffer Cell Ectoenzymes Precedes Deposition of Amyloid Protein A....Pages 225-231
Specific Chemical Dissociation of Fibrillar and Non-Fibrillar Components of Amyloid Deposits....Pages 233-238
Front Matter....Pages 239-239
Degradation of AA-Amyloid, Clinical Experience: An Introduction....Pages 241-243
In Vivo Degradation of Protein SAA to Protein AA and Incorporation in Amyloid Fibrils....Pages 245-251
Isolation and Characterization of the Inhibitor of Amyloid Degrading Factor....Pages 253-259
Amyloid-Agarose Plate Test: Ultrastructural Changes in the Fibril and its Association with Human Neutrophil Elastase....Pages 261-265
Decreased Esterase Activity in Serum of Patients with Reactive Systemic (AA) Amyloidosis....Pages 267-272
Enhanced Degradation of Amyloid AA Proteins by Enzyme Activation: A Possible Model for a Therapeutic Approach....Pages 273-277
Does Serum Degrade Amyloid Fibrils? Failure to Confirm Enzymatic Degradation of Amyloid A Fibrils as the Basis of the so-called “Amyloid Degrading Activity” of Serum....Pages 279-284
Front Matter....Pages 285-285
Statement Regarding Nomenclature for the Protein Known as Prealbumin, Which is also (Recently) Called Transthyretin....Pages 287-288
Family Studies of Transthyretin (Prealbumin) and its Methionine 30 Variant in Portuguese Patients with Familial Amyloidotic Polyneuropathy....Pages 289-294
Serum Concentrations of Prealbumin and Retinol Binding Protein in Familial Amyloid Patients from 15 Kinships....Pages 295-301
Pre-Albumin and Retinol Binding Protein Serum Concentrations in the Brazilian Type (Portuguese) of Familial Polyneuropathy....Pages 303-304
Clinical Investigations of Autonomic Heart Regulation and Renal Function of Familial Amyloidotic Polyneuropathy....Pages 305-311
Front Matter....Pages 285-285
Identification of Amyloid Prealbumin Variant in Familial Amyloidotic Polyneuropathy of Japanese Origin; Three Patients of Different Pedigrees....Pages 313-321
Monoclonal Antibodies to Serum Prealbumin of a Patient with Familial Amyloidotic Polyneuropathy....Pages 323-330
Salient Structural Features of Low Molecular Weight Amyloid Fibril Proteins in Familial Amyloid Polyneuropathy of Japanese Origin....Pages 331-337
Immunohistochemical Studies on Autopsied Organs of Familial Amyloid Polyneuropathy in Relation with Amyloid Protein....Pages 339-347
Studies on Blood Markers and Amyloid Fibril in the Arao Focus of Familial Amyloid Polyneuropathy....Pages 349-354
Familial Amyloidotic Polyneuropathy Type I and Type II: Characterization of Two Distinct Genetic Defects and Identification of Carriers of Each Gene....Pages 355-366
Familial Amyloidotic Polyneuropathy Type I: Characterization of the Prealbumin Amyloid Subunit and Precursor Protein....Pages 367-373
Immunohistochemical Studies on Hereditary Amyloidosis of the Finnish Type....Pages 375-377
Late Onset Hereditary Amyloidosis in a Family From Texas....Pages 379-383
Genetic Heterogeneity of Familial Amyloid Polyneuropathies of Jewish Type....Pages 385-389
Prealbumin Nature of the Amyloid in Familial Amyloid Cardiomyopathy of Danish Origin....Pages 391-399
Diagnosis of Familial Amyloidotic Polyneuropathy by Recombinant DNA Techniques....Pages 401-405
Biochemical Nature of Familial Amyloidotic Polyneuropathy and a New Diagnostic Method by Radioimmunoassay....Pages 407-414
Clinical and Pathological Studies of Familial Amyloid Polyneuropathy (FAP), with Special Reference to Nephropathy and Cardiopathy....Pages 415-428
Cardiac Disorders and Autonomic Nervous System Involvement in Familial Amyloidosis....Pages 429-434
Treatment of Orthostatic Hypotension in Familial Amyloid Polyneuropathy with L-Threo-3,4-Dihydroxyphenylserine....Pages 435-440
Review of Clinical Records and Therapeutic Trials in Familial Anyloidotic Polyneuropathy (Type 1) in Japan....Pages 441-445
Front Matter....Pages 447-447
Light Chain Variable Region Subgroups of Monoclonal Immunoglobulins in Amyloidosis AL....Pages 449-462
Structural Studies of the Variable Region of Immunoglobulin Light-Chain-Type Amyloid Fibril Proteins....Pages 463-475
Amyloidogenicity and Subgroups of Human Lambda Bence Jones Proteins....Pages 477-481
Front Matter....Pages 447-447
Appearance of Systemic Amyloidosis in Myeloma with Amyloidogenic Bence Jones Protein....Pages 483-489
Complete Primary Structure of an Immunoglobulin λII-Chain Derived Amyloid Fibril Protein (HAR)....Pages 491-496
Some Structural Factors Involved in Amyloid Fibril Formation by Lambda VI Light Chain Proteins....Pages 497-502
Polymorphism in a Kappa I Primary (AL) Amyloid Protein (BAN)....Pages 503-507
Analysis of the Monoclonal Components in Systemic AL-Amyloidosis....Pages 509-515
Structural and Immunologic Studies of a Kappa Amyloid Fibril Protein....Pages 517-524
Molecular Heterogeneity and γ-Carboxyglutamic Acid Content of Bence-Jones Proteins: Possible Relevance to Amyloidogenicity....Pages 525-534
Aberrant Immunoglobulin Synthesis in AL Amyloid....Pages 535-542
Front Matter....Pages 543-543
Primary Systemic Amyloidosis (AL): Comparison of Melphalan-Prednisone vs. Colchicine Treatment in 101 Cases....Pages 545-557
The Life Span of Patients with Primary (AL) Amyloidosis and the Effect of Colchicine Treatment....Pages 559-565
The Impact of Colchicine on the Amyloidosis of Familial Mediterranean Fever (FMF)....Pages 567-570
Treatment of Systemic AA Amyloidosis....Pages 571-582
Splenic Function in Amyloidosis....Pages 583-590
Does the Urinary Protein Pattern in AA-Amyloid Nephropathy Differ from that in Other Nephropathies?....Pages 591-597
Classification of Amyloid Syndromes from Tissue Sections Using Antibodies Against Various Amyloid Fibril Proteins: Report of 142 Cases....Pages 599-605
Clinical, Pathological, and Functional Findings in Amyloid Nephropathy....Pages 607-612
Fine Needle Aspiration Biopsy of Abdominal Subcutaneous Fat Tissue for the Diagnosis and Typing of Amyloidosis....Pages 613-615
Non-Invasive Techniques for Demonstrating Cardiac Involvement in the Acquired Forms of Systemic Amyloidosis....Pages 617-620
Soft-Tissue Uptake of 99m Tc-Diphosphonate and 99m Tc-Pyrophosphate in Systemic AA and AL Amyloidosis....Pages 621-627
Plasma Exchange in the Treatment of Patients with Systemic Amyloidosis....Pages 629-637
Front Matter....Pages 639-639
Research in Aging and Amyloidosis....Pages 641-645
Amyloid and Aging — An Hypothesis Involving So-Called Amyloid Degrading Activity (ADA)....Pages 647-652
Senile Systemic Amyloidosis....Pages 653-658
Varied Composition and Nature of Senile Localized Amyloid: Implications for Varied Mechanisms of Pathogenesis....Pages 659-668
A New Senile Amyloid Fibril Protein and Its Putative Precursor in Senescence Accelerated Mouse (SAM)....Pages 669-677
Amyloid Deposition in the Articular Structures of Senescence Accelerated Mouse (SAM)....Pages 679-682
Antioxidants in Experimental Amyloidosis of Young and Old Mice....Pages 683-690
Front Matter....Pages 691-691
Amyloid Research as a Paradigm for Alzheimer’s Disease....Pages 693-701
Neurobiological Probes for Specific Constituents of Senile Plaques in Aging and Alzheimer’s Disease....Pages 703-708
Biochemical and Structural Studies of Paired Helical Filaments and Senile Plaque Amyloid in Alzheimer’s Disease....Pages 709-715
Alzheimer Neurofibrillary Tangle and Its Relationship with Plaque Core Amyloid....Pages 717-722
Cerebral Amyloid and Alzheimer’s Syndrome....Pages 723-732
Prion Amyloids in Scrapie and Creutzfeldt-Jakob Disease....Pages 733-742
Senile Cerebral Amyloid — Evidence for a Neuronal Origin of the Fibril Protein....Pages 743-749
Isolation and Partial Characterization of Alzheimer Neurofibrillary Tangles....Pages 751-759
Amyloid Fibrils in Hereditary Cerebral Hemorrhage with Amyloidosis (HCHWAS) is Related to Cystatin (Gamma Trace)....Pages 761-766
Cerebral Amyloid Angiopathy Causing Intracranial Hemorrhage a Clinicopathological Study of 12 Cases....Pages 767-782
The Role of Cerebral Amyloid Angiopathy in Dementia of Alzheimer’s Type (Preliminary Results)....Pages 783-788
Hereditary Central Nervous System γ-Trace Amyloid Angiopathy and Stroke in Icelandic Families....Pages 789-801
Front Matter....Pages 803-803
Amyloid Associated with Calcifying Epithelial Odontogenic Tumor — A New Type of Amyloid Fibril Protein CEOT....Pages 805-811
Front Matter....Pages 803-803
Immunological Homology of the Amyloid of Insulinoma and the Islet Amyloid of the Aged: Biochemical Characterization of the Insulinoma Amyloid....Pages 813-820
Histopathology of Cutaneous Amyloid: A Comparative Study on 144 Cases of Localized Cutaneous Amyloidosis and 20 Cases of Systemic Amyloidosis....Pages 821-828
Histological Evidence of Amyloid Deposition in Old Thrombotic Lesions and in Longterm Bioprosthetic Cardiac Valve Implants in Man: Two Recently Observed and Possibly Related Forms of Localized Amyloidosis of the Cardiovascular System....Pages 829-835
Back Matter....Pages 837-857




نظرات کاربران